EDIBLE GARDEN AG INC (EDBL)

US28059P3038 - Common Stock

0.3324  0 (-0.95%)

After market: 0.3438 +0.01 (+3.43%)

Fundamental Rating

2

Overall EDBL gets a fundamental rating of 2 out of 10. We evaluated EDBL against 89 industry peers in the Food Products industry. EDBL may be in some trouble as it scores bad on both profitability and health. EDBL is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EDBL has reported negative net income.
EDBL had a negative operating cash flow in the past year.

1.2 Ratios

EDBL has a Return On Assets of -137.74%. This is amonst the worse of the industry: EDBL underperforms 96.39% of its industry peers.
With a Return On Equity value of -374.59%, EDBL is not doing good in the industry: 91.57% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -137.74%
ROE -374.59%
ROIC N/A
ROA(3y)-156.88%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 18.27%, EDBL is in line with its industry, outperforming 40.96% of the companies in the same industry.
EDBL's Gross Margin has declined in the last couple of years.
EDBL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.83%
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

EDBL does not have a ROIC to compare to the WACC, probably because it is not profitable.
EDBL has more shares outstanding than it did 1 year ago.
EDBL has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -6.96, we must say that EDBL is in the distress zone and has some risk of bankruptcy.
EDBL's Altman-Z score of -6.96 is on the low side compared to the rest of the industry. EDBL is outperformed by 91.57% of its industry peers.
EDBL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
EDBL's Debt to Equity ratio of 0.23 is fine compared to the rest of the industry. EDBL outperforms 61.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -6.96
ROIC/WACCN/A
WACC7.32%

2.3 Liquidity

EDBL has a Current Ratio of 1.11. This is a normal value and indicates that EDBL is financially healthy and should not expect problems in meeting its short term obligations.
EDBL's Current ratio of 1.11 is on the low side compared to the rest of the industry. EDBL is outperformed by 73.49% of its industry peers.
EDBL has a Quick Ratio of 1.11. This is a bad value and indicates that EDBL is not financially healthy enough and could expect problems in meeting its short term obligations.
EDBL has a worse Quick ratio (0.81) than 60.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.81

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.68% over the past year.
EDBL shows a small growth in Revenue. In the last year, the Revenue has grown by 7.88%.
EDBL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.17% yearly.
EPS 1Y (TTM)87.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.8%
Revenue 1Y (TTM)7.88%
Revenue growth 3Y14.17%
Revenue growth 5YN/A
Sales Q2Q%-21.46%

3.2 Future

EDBL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.09% yearly.
The Revenue is expected to grow by 22.41% on average over the next years. This is a very strong growth
EPS Next Y-324.33%
EPS Next 2Y37.1%
EPS Next 3Y25.09%
EPS Next 5YN/A
Revenue Next Year7.32%
Revenue Next 2Y23.63%
Revenue Next 3Y22.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EDBL. In the last year negative earnings were reported.
Also next year EDBL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EDBL's earnings are expected to grow with 25.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.1%
EPS Next 3Y25.09%

More info and screens

0

5. Dividend

5.1 Amount

EDBL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDIBLE GARDEN AG INC

NASDAQ:EDBL (1/6/2025, 5:25:20 PM)

After market: 0.3438 +0.01 (+3.43%)

0.3324

0 (-0.95%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners0.43%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner Change2.08%
Market Cap6.49M
Analysts82.86
Price Target0.51 (53.43%)
Short Float %0.12%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-0.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.81%
Min EPS beat(2)-48.2%
Max EPS beat(2)71.82%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.67%
Min Revenue beat(2)-31.75%
Max Revenue beat(2)-5.6%
Revenue beat(4)0
Avg Revenue beat(4)-11.85%
Min Revenue beat(4)-31.75%
Max Revenue beat(4)-4.16%
Revenue beat(8)3
Avg Revenue beat(8)-2.92%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-95.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)88%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 1.99
P/tB 2.02
EV/EBITDA N/A
EPS(TTM)-30.3
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS0.72
BVpS0.17
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -137.74%
ROE -374.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.27%
FCFM N/A
ROA(3y)-156.88%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.83%
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.87%
Cap/Sales 2.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.81
Altman-Z -6.96
F-Score4
WACC7.32%
ROIC/WACCN/A
Cap/Depr(3y)100.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.8%
EPS Next Y-324.33%
EPS Next 2Y37.1%
EPS Next 3Y25.09%
EPS Next 5YN/A
Revenue 1Y (TTM)7.88%
Revenue growth 3Y14.17%
Revenue growth 5YN/A
Sales Q2Q%-21.46%
Revenue Next Year7.32%
Revenue Next 2Y23.63%
Revenue Next 3Y22.41%
Revenue Next 5YN/A
EBIT growth 1Y11.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.12%
OCF growth 3YN/A
OCF growth 5YN/A